mesalamine has been researched along with Cancer, Radiation-Induced in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jahraus, CD | 1 |
| Rubin, DT | 1 |
| Scherl, EJ | 1 |
| Bettenhausen, D | 1 |
1 other study available for mesalamine and Cancer, Radiation-Induced
| Article | Year |
|---|---|
Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.
Topics: Aminosalicylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; | 2005 |